News
An OHE report analyses the rise in NICE’s optimised decisions from 2025 to 2024 and how they affect patient access, HTA ...
Long-acting therapies offer value for chronic disease, improving adherence and outcomes. This OHE report highlights HTA gaps, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback